-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R+X9P/EMbjt7Xweqh/hyOGLiBpIvS71aIFaLZxgMZ+GXOtWQnqpbo2aWIdXrfQrX aAAKzDKIIUDdbxa0NGyGTQ== 0001399883-10-000004.txt : 20100618 0001399883-10-000004.hdr.sgml : 20100618 20100618130819 ACCESSION NUMBER: 0001399883-10-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100617 FILED AS OF DATE: 20100618 DATE AS OF CHANGE: 20100618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sharbaugh William J CENTRAL INDEX KEY: 0001399883 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 10905325 MAIL ADDRESS: STREET 1: C/O PHARMACEUTICAL PRODUCT DEVELOPMENT STREET 2: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-06-17 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001399883 Sharbaugh William J 929 NORTH FRONT STREET WILMINGTON NC 28401 0 1 0 0 Chief Operating Officer Common Stock 11803 D Stock Options (to buy) 26.64 2010-06-17 4 A 0 30000 0 A 2011-06-17 2020-06-17 Common Stock 30000 30000 D Stock Options (to buy) 20.45 2011-02-25 2020-02-25 Common Stock 62104 62104 D Stock Options (to buy) 25.74 2010-02-18 2019-02-18 Common Stock 62104 62104 D Stock Options (to buy) 19.94 2009-11-20 2018-11-20 Common Stock 27947 27947 D Stock Options (to buy) 37.69 2009-10-03 2018-10-03 Common Stock 27947 27947 D Stock Options (to buy) 43.26 2009-02-20 2018-02-20 Common Stock 62104 62104 D Stock Options (to buy) 35.26 2008-05-31 2017-05-30 Common Stock 77630 77630 D 10,000 shares of restricted stock were granted upon the Reporting Person's acceptance of employment. These shares vest in three equal increments on 5/31/08, 5/31/09 and 5/31/10. These options vest in three equal increments on 6/17/11, 6/17/12 and 6/17/13. Exercise price and share amounts reflect an anti-dilution adjustment made in connection with the June 14, 2010 spin-off of Furiex Pharmaceuticals, Inc. These options vest in three equal increments on 2/25/11, 2/25/12 and 2/25/13. These options vest in three equal increments on 2/18/10, 2/18/11 and 2/18/12. These options vest in three equal increments on 11/20/09, 11/20/10 and 11/20/11. These options vest in three equal increments on 10/3/09, 10/3/10 and 10/3/11. These options vest in three equal increments on 2/20/09, 2/20/10 and 2/20/11. These options vest in three equal increments on 5/31/08, 5/31/09 and 5/31/10. Lisa C. Noecker attorney-in-fact for William J. Sharbaugh 2010-06-18 -----END PRIVACY-ENHANCED MESSAGE-----